Observation of change in Clinical Global Impression scores in Schizophrenia Patients receiving Seroquel XR Treatment
Study identifier:NIS-NLV-SER-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Observation of change in Clinical Global Impression scores in Schizophrenia Patients receiving Seroquel XR Treatment
Medical condition
schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
80
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Sept 2008
Primary Completion Date: 01 Mar 2009
Study Completion Date: 01 Mar 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Adult schizophrenia patients already on Seroquel XR therapy | - |
Contacts
Investigators
Principal Investigator
Agrita Hartmane
AstraZeneca Latvia
